Literature DB >> 35157308

The feasibility and potential of pharmacogenetics to reduce adverse drug events in nursing home residents.

Christine E Kistler1,2, Charles Adrian Austin3, Junjian J Liu4, Madison Cauble5, Andrew Wise6, Sheel M Patel7, Kimberly Ward2, Tim Wiltshire7, Fei Zou8,9, Andy H Szeto7, Daniel J Crona7,10.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35157308      PMCID： PMC9106864          DOI： 10.1111/jgs.17679

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   7.538


× No keyword cloud information.
  12 in total

Review 1.  Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.

Authors:  J K Hicks; J R Bishop; K Sangkuhl; D J Müller; Y Ji; S G Leckband; J S Leeder; R L Graham; D L Chiulli; A LLerena; T C Skaar; S A Scott; J C Stingl; T E Klein; K E Caudle; A Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2015-06-29       Impact factor: 6.875

2.  A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation.

Authors:  A F Jorm
Journal:  Psychol Med       Date:  1994-02       Impact factor: 7.723

3.  American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2019-01-29       Impact factor: 5.562

4.  Assessment of the clinical utility of pharmacogenetic guidance in a comprehensive medication management service.

Authors:  Idaliz Rodríguez-Escudero; Julio A Cedeño; Ileana Rodríguez-Nazario; Gledys Reynaldo-Fernández; Leyanis Rodríguez-Vera; Niretzy Morales; Braulio Jiménez-Vélez; Gualberto Ruaño; Jorge Duconge
Journal:  J Am Coll Clin Pharm       Date:  2020-05-02

Review 5.  Applications for pharmacogenomics in pharmacy practice: A scoping review.

Authors:  Meagan Hayashi; Dalia A Hamdy; Sherif Hanafy Mahmoud
Journal:  Res Social Adm Pharm       Date:  2021-08-20

6.  Clinical Implementation of Pharmacogenetic Decision Support Tools for Antidepressant Drug Prescribing.

Authors:  Zane Zeier; Linda L Carpenter; Ned H Kalin; Carolyn I Rodriguez; William M McDonald; Alik S Widge; Charles B Nemeroff
Journal:  Am J Psychiatry       Date:  2018-04-25       Impact factor: 18.112

Review 7.  Pharmacogenomics.

Authors:  Dan M Roden; Howard L McLeod; Mary V Relling; Marc S Williams; George A Mensah; Josh F Peterson; Sara L Van Driest
Journal:  Lancet       Date:  2019-08-05       Impact factor: 79.321

8.  Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19.

Authors:  J J Swen; T van der Straaten; J A M Wessels; M L Bouvy; E E W Vlassak; W J J Assendelft; H-J Guchelaar
Journal:  Eur J Clin Pharmacol       Date:  2011-10-08       Impact factor: 2.953

9.  Interrogation of CYP2D6 Structural Variant Alleles Improves the Correlation Between CYP2D6 Genotype and CYP2D6-Mediated Metabolic Activity.

Authors:  Rachel Dalton; Seung-Been Lee; Katrina G Claw; Bhagwat Prasad; Brian R Phillips; Danny D Shen; Lai Hong Wong; Mitch Fade; Matthew G McDonald; Maitreya J Dunham; Douglas M Fowler; Allan E Rettie; Erin Schuetz; Timothy A Thornton; Deborah A Nickerson; Andrea Gaedigk; Kenneth E Thummel; Erica L Woodahl
Journal:  Clin Transl Sci       Date:  2019-10-25       Impact factor: 4.689

Review 10.  Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy.

Authors:  Kristine R Crews; Andrew A Monte; Rachel Huddart; Kelly E Caudle; Evan D Kharasch; Andrea Gaedigk; Henry M Dunnenberger; J Steven Leeder; John T Callaghan; Caroline Flora Samer; Teri E Klein; Cyrine E Haidar; Sara L Van Driest; Gualberto Ruano; Katrin Sangkuhl; Larisa H Cavallari; Daniel J Müller; Cynthia A Prows; Mohamed Nagy; Andrew A Somogyi; Todd C Skaar
Journal:  Clin Pharmacol Ther       Date:  2021-02-09       Impact factor: 6.903
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.